"Daily occurrence" is fairly obvious if you consider script-kiddies and small time criminal activities. As for electoral security, plenty of post-2013 events already to check the validity (and exaggerations) of this. What should concern is how much of this will be state sponsored.
…and also how much big tech companies want to block the spread of this misinformation.
Because, for example, X/twitter knows that the same (misinformation) article/link is shared by 100 accounts created few days before. But X doesn’t block the sharing of this link/article because it makes more money as it is more shared/interacted.
Depends with use case -- a single piece of healthcare data would easily go for triple digits, while high volume data (blogs, text, images) would go for single or double.
The investment model also throws things a bit off, since the value of contract for profits also has a worth, and fluctuates with company performance.
Lots. I think one of the only arguments that needs to be made against things like gain-of-function research is this. [1] That's an incomprehensive list various announced biosecurity incidents.
Just since 2000 we've had lab incidents, including leaks, with: anthrax, west nile virus, SARS, COVID (not implying China - there was a confirmed COVID leak in Taiwan), ebola, tuberculosis, dengue, smallpox, zika, polio, and more. And they're happening all throughout the world. That includes the US, China, Russia, Japan, Germany, Australia, UK, South Korea, Hungary, France, Taiwan, Netherlands, and more. Incidents specified as coming from BSL-4 labs include ebola and SARS, though the BSL level is not specified at all for most incidents.
And I would take that is an extremely incomprehensive list given that many incidents are likely going to be tucked away or classified. There's playing with fire, and then there's this... which increasingly more feels like standing around a fire and seeing what happens if you start dumping kerosene into it, all in the name of firefighting - of course.
I don't think it was a modern BSL-4 standard lab, but smallpox escaped and killed someone in the UK. Now (at least in theory) only the US and Russia have samples in special government BSL-4 labs. Other countries could make it from sequence though.
Edit: I can't reply, so I'll say that an extinct horsepox virus was recreated from sequence, the same procedure in theory should work on smallpox
Smallpox is 186 kilobases in size. It's pretty hard to synthesize from scratch.
Not impossible, but hard.
Then you'll still need to assemble the viable viral particles. This will probably require the creation of artificial chromosomes needed for the viral replication, and then innoculating human cell culture with them, alongside with the synthetic viral DNA.
This is a level that requires years of work from a major biolab.
Always harder than you think of course - but the thing about molecular biology is unlike nuclear physics, most of the equipment you need is relatively cheap and readily available.
So the tools are there.
However on the other hand - making something the right mix of lethal, but still able to spread I suspect is incredibly hard - if it was easy we'd all be dead already ( from viruses etc naturally evolving ).
>I don't think it was a modern BSL-4 standard lab, but smallpox escaped and killed someone in the UK.
That was in 1978! I believe we didn't have biosafety levels back then in the UK.
Edit: at least the BSL levels came 6 years later, but the UK has different names for those
>Over the next two decades, growing CDC, NIH, and OSHA participation in ABSA annual meetings further solidified biosafety guidelines, culminating in the 1984 publication of the first edition of the text, Biosafety in Microbiological and Biomedical Laboratories (BMBL). The BMBL guidelines laid out four levels of increasingly intensive safety practices, equipment, facilities, and engineering controls to be employed in the safe handling of microbial agents: Biosafety Levels 1, 2, 3, and 4 (BSL-1, -2, -3, and -4),
